British drugs giant accused of hiding link between heartburn medicine and cancer
Zantac went on sale in the UK in 1981. But in 2019, GSK withdrew it in the UK and US over fears that the ingredient ranitidine created a carcinogenic chemical
You are not logged in so some information on this page has been withheld. To see more, please log in.
since
auto-detected in 5 stories
62 days ago
page 1 of 1